QAngio XA 3DQFR® Angiography based WIRE-FREE computational functional measurement.

QFR® (Quantitative Flow Ratio) is based upon 3D QCA coronary artery reconstruction and subsequent frame counting for the calculation of the flow velocity of the contrast media through the target vessel.

QFR® is proven to have acceptable correlation and agreement with FFR, with over 14,000+ patients and 17,000+ lesions assessed in 180+ peer-reviewed articles.

No guide catheter, no pressure wire and no adenosine.

Significantly reduces treatment costs and procedure time.

In the FAVOR III China study, QFR® is proven to reduce relative risk of MACE by 34% compared with the angio-guided method. (5.5% vs 8.8%).

Enrollment of 2,000 patients globally has now completed for FAVOR III E-J.

Enrolling now for Australian multi-centre AVALON study.

Manufactured in Netherlands.

NOTE: This medical device can only be supplied and used by a qualified healthcare practitioner.

NOTE: Always follow 'Instructions For Use' for indications, warnings, precautions & device preparation.